Net income increased 112.6%
Net income changed +112.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +112.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +300.0% from the comparable as-filed period.
Operating cash flow changed +137.8% from the comparable as-filed period.
Debt changed +28.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +73.0% from the comparable as-filed period.
Capital expenditure changed +37.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed -480 basis points from the comparable as-filed period.
Inventory / revenue changed -299 basis points from the comparable as-filed period.
Stock-based compensation changed +208.7% from the comparable as-filed period.
SBC / revenue changed +45 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +8.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.